| Medication |
Total (n=1,537) |
CHD diagnosed (n=1,266) |
CHD not diagnosed (n=152) |
| RAS blocker |
1,087 (70.7%) |
923 (72.9%) |
77 (50.7%) |
| Beta blocker |
1,086 (70.7%) |
935 (73.9%) |
75 (49.3%) |
| Aggregation inhibitor |
881 (57.3%) |
769 (60.7%) |
44 (28.9%) |
| Nitrate (short-acting) |
502 (32.7%) |
417 (32.9%) |
48 (31.6%) |
| Calcium antagonist |
348 (22.6%) |
287 (22.7%) |
30 (19.7%) |
| Nitrate (long-acting) |
353 (23.0%) |
308 (24.3%) |
20 (13.2%) |
|
